Nevirapine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-505 -
Package NDC
31722-505-01 -
Package NDC
31722-505-05 -
Package NDC
31722-505-10 -
Package NDC
31722-505-60 -
Application number
ANDA078584 -
SPL ID
e5515515-0ee0-e288-e053-2995a90a3d7c -
SPL set ID
61409678-d2f6-42cd-b03d-b26b11b39641 -
UNII
99DK7FVK1H -
RxCUI
199422
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- Nevirapine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Nevirapine",
"splId": "e5515515-0ee0-e288-e053-2995a90a3d7c",
"labels": [
{
"setId": "61409678-d2f6-42cd-b03d-b26b11b39641",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61409678-d2f6-42cd-b03d-b26b11b39641",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=61409678-d2f6-42cd-b03d-b26b11b39641"
}
],
"routes": [
"ORAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (31722-505-01)",
"package_ndc": "31722-505-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20120523"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (31722-505-05)",
"package_ndc": "31722-505-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20120523"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (31722-505-10)",
"package_ndc": "31722-505-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20120523"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (31722-505-60)",
"package_ndc": "31722-505-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20120523"
}
],
"productId": "31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "31722-505",
"deaSchedule": null,
"genericName": "Nevirapine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NEVIRAPINE",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA078584",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120523",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175463",
"N0000175460",
"N0000009948",
"N0000190118",
"N0000187064"
],
"unii": [
"99DK7FVK1H"
],
"rxcui": [
"199422"
],
"spl_set_id": [
"61409678-d2f6-42cd-b03d-b26b11b39641"
],
"pharm_class_epc": [
"Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
"Cytochrome P450 3A Inducers [MoA]",
"Cytochrome P450 2B6 Inducers [MoA]"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c"